Informace o publikaci

Common Variable Immunodeficiency patients with a phenotypic profile of immunosenescence present with thrombocytopenia

Autoři

STUCHLÝ Jan KANDEROVÁ Veronika VLKOVÁ Marcela HEŘMANOVÁ Ivana SLÁMOVÁ Lucie PELÁK Ondřej TARALDSRUD Eli JÍLEK Dalibor KRALÍČKOVÁ Pavlína FEVANG Borre TRKOVÁ Marie HRUŠÁK Ondřej FROŇKOVÁ Eva ŠEDIVÁ Anna LITZMAN Jiří KALINA Tomáš

Rok publikování 2017
Druh Článek v odborném periodiku
Časopis / Zdroj Scientific Reports
Fakulta / Pracoviště MU

Lékařská fakulta

Citace
Doi http://dx.doi.org/10.1038/srep39710
Obor Imunologie
Klíčová slova B-CELLS; CVID PATIENTS; T-CELLS; RHEUMATOID-ARTHRITIS; DIFFERENTIATION; DISEASE; CLASSIFICATION; MUTATIONS; ABNORMALITIES; DEFICIENCY
Popis Common variable immunodeficiency (CVID) is a heterogeneous group of diseases. Our aim was to define sub-groups of CVID patients with similar phenotypes and clinical characteristics. Using eight-color flow cytometry, we analyzed both B-and T-cell phenotypes in a cohort of 88 CVID patients and 48 healthy donors. A hierarchical clustering of probability binning "bins" yielded a separate cluster of 22 CVID patients with an abnormal phenotype. We showed coordinated proportional changes in naive CD4+ T-cells (decreased), intermediate CD27-CD28+ CD4+ T-cells (increased) and CD21low B-cells (increased) that were stable for over three years. Moreover, the lymphocytes' immunophenotype in this patient cluster exhibited features of profound immunosenescence and chronic activation. Thrombocytopenia was only found in this cluster (36% of cases, manifested as Immune Thrombocytopenia (ITP) or Evans syndrome). Clinical complications more frequently found in these patients include lung fibrosis (in 59% of cases) and bronchiectasis (55%). The degree of severity of these symptoms corresponded to more deviation from normal levels with respect to CD21low B-cells, naive CD4+ and CD27-CD28+ over three years. Moreover, th-cells. Next-generation sequencing did not reveal any common genetic background. We delineate a subgroup of CVID patients with activated and immunosenescent immunophenotype of lymphocytes and distinct set of clinical complications without common genetic background.

Používáte starou verzi internetového prohlížeče. Doporučujeme aktualizovat Váš prohlížeč na nejnovější verzi.

Další info